Article

HHS Auditors Find Possible Excess Medicare Payments for Hospice Beneficiaries' Drugs

The Medicare program could be paying multiple times for prescription drugs for hospice beneficiaries, a new federal report suggests.

Read the full story: http://tinyurl.com/6v4bews

Source: ModernHealthcare.com

HHS' inspector general's office conducted a nationwide review of prescription drugs for hospice beneficiaries between January and December 2009 and found that Medicare Part D paid for a variety of prescription medications—including analgesic, anti-nausea, laxative and anti-anxiety drugs and drugs to treat chronic obstructive pulmonary disease—that should have been covered under the per diem payments made to hospice organizations under Medicare Part A. Investigators found 198,543 hospice beneficiaries who, through the Medicare Part D program, received 677,022 prescription drugs that potentially should have been covered under the daily payments made to hospice organizations. Meanwhile, Part D paid pharmacies more than $33.6 million for these drugs, and beneficiaries paid more than $3.8 million in copayments.

Related Videos
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center (UPMC)
JC Scott, CEO and president of The Pharmaceutical Care Management Association (PCMA)
Galen Shearn-Nance, BS, and Johnie Rose, MD, PhD
Galen Shearn-Nance, BS
Dr Johnie Rose
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
Tiffany Meng, PharmD, oncology pharmacist, UCSF Health
Dr Andrew S. Oseran
o Richard Hughes IV, JD, MPH, Epstein Becker Green
Dr Andrew S. Oseran
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo